Asset Details
Do you wish to reserve the book?
Altered Activation of Innate Immunity Associates with White Matter Volume and Diffusion in First-Episode Psychosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Altered Activation of Innate Immunity Associates with White Matter Volume and Diffusion in First-Episode Psychosis
Do you wish to request the book?
Altered Activation of Innate Immunity Associates with White Matter Volume and Diffusion in First-Episode Psychosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Altered Activation of Innate Immunity Associates with White Matter Volume and Diffusion in First-Episode Psychosis
2015
Overview
First-episode psychosis (FEP) is associated with inflammatory and brain structural changes, but few studies have investigated whether systemic inflammation associates with brain structural changes in FEP. Thirty-seven FEP patients (median 27 days on antipsychotic medication), and 19 matched controls were recruited. Serum levels of 38 chemokines and cytokines, and cardiovascular risk markers were measured at baseline and 2 months later. We collected T1- and diffusion-weighted MRIs with a 3 T scanner from the patients at baseline. We analyzed the association of psychosis-related inflammatory markers with gray and white matter (WM) volume using voxel-based morphometry and WM diffusion using tract-based spatial statistics with whole-brain and region-of-interest (ROI) analyses. FEP patients had higher CCL22 and lower TGFα, CXCL1, CCL7, IFN-α2 and ApoA-I than controls. CCL22 decreased significantly between baseline and 2 months in patients but was still higher than in controls. The association between inflammatory markers and FEP remained significant after adjusting for age, sex, smoking and BMI. We did not observe a correlation of inflammatory markers with any symptoms or duration of antipsychotic treatment. Baseline CCL22 levels correlated negatively with WM volume and positively with mean diffusivity and radial diffusivity bilaterally in the frontal lobes in ROI analyses. Decreased serum level of ApoA-I was associated with smaller volume of the medial temporal WM. In whole-brain analyses, CCL22 correlated positively with mean diffusivity and radial diffusivity, and CXCL1 associated negatively with fractional anisotropy and positively with mean diffusivity and radial diffusivity in several brain regions. This is the first report to demonstrate an association between circulating chemokine levels and WM in FEP patients. Interestingly, CCL22 has been previously implicated in autoimmune diseases associated with WM pathology. The results suggest that an altered activation of innate immunity may contribute to WM damage in psychotic disorders.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Adult
/ Aging
/ Antipsychotic Agents - therapeutic use
/ Apolipoprotein A-I - immunology
/ Brain
/ Chemokine CCL22 - immunology
/ Chemokine CXCL1 - immunology
/ Diffusion Magnetic Resonance Imaging
/ Drugs
/ Female
/ Gene Expression - immunology
/ Humans
/ Image Processing, Computer-Assisted
/ Immunity
/ Interferon-alpha - immunology
/ Lobes
/ Male
/ Markers
/ Mean
/ Patients
/ Proteins
/ Psychotic Disorders - drug therapy
/ Psychotic Disorders - immunology
/ Psychotic Disorders - pathology
/ Smoking
/ Studies
/ Transforming Growth Factor alpha - blood
